Welcome to the third annual CTCA REVIEW! The goal of the CTCA REVIEW is to efficiently
discuss the most recent clinical advances and trials in the rapidly evolving field
of malignant hematology and oncology. This program is unique in addressing the questions
and controversies that have emerged from the latest data presented at both the American
Society of Hematology (ASH) and American Society of Clinical Oncology (ASCO) annual
After attending the CTCA REVIEW, participants should be able to:
- Interpret new and emerging data presented at the ASH and ASCO annual conferences*
- Incorporate newer evidence-based data to assess the care of patients with
- Incorporate knowledge gained into appropriate management strategies to improve
outcomes in patients with cancer
- Utilize current standards of care for patients with cancer
The CTCA REVIEW is designed to meet the educational needs of healthcare providers
involved in the care of oncology patients, including medical oncologists, hematologists,
surgical oncologists, radiation oncologists, diagnostic radiologists, pathologists,
oncology fellows, resident trainees, primary care providers, advanced care practitioners,
physician assistants, nurses, chiropractors, naturopathic physicians, and pharmacists.
- Interactive Presentations
- Patient Case Presentations
- Faculty Panel Discussion
- Question and Answer Sessions
A course evaluation form will be provided to CTCA REVIEW participants to have
the opportunity to comment on any perceived commercial bias in the presentations,
as well as to identify future educational topics. In addition, participants will
have the opportunity to comment on the value of the program content on their practice
decisions, performance improvement activities, or possible impact on patient health
This activity has been planned and implemented in accordance with the Essential
Areas and policies of the Accreditation Council for Continuing Medical Education
(ACCME) through the joint sponsorship of Dannemiller and Athena Education Group.
Dannemiller is accredited by the ACCME to provide continuing medical education for
physicians. Dannemiller designates this live activity for a maximum of 7.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate
with the extent of their participation in the program.
Dannemiller is a provider approved by the California Board of Registered
Provider Number 4229. This activity has been approved for 7.0 contact hours. Please
Note: CBRN credit is not accepted by the Michigan and Utah state licensing boards.
As a provider accredited by ACCME, Dannemiller must ensure balance, independence,
objectivity and scientific rigor in its educational activities. Course director(s),
planning committee, faculty, and all others who are in a position to control the
content of this educational activity are required to disclose all relevant financial
relationships with any commercial interest related to the subject matter of the
educational activity. Safeguards against commercial bias have been put in place.
Faculty also will disclose any off-label and/or investigational use of pharmaceuticals
or instruments discussed in their presentation. Disclosure of this information will
be published in course materials so those participants in the activity may formulate
their own judgment regarding the presentation.
Dannemiller is accredited by the Accreditation Council for Pharmacy Education
as a provider of continuing pharmacy education. This activity is a knowledge based
activity. Dannemiller has assigned 7.75 contact hours (0.775 CEU) of continuing
pharmacy education credit for participation in this activity. ACPE program number
CME Certificates and Attendance Verification Certificates
Certificates awarding AMA PRA Category 1 Credit™ or certificates documenting
attendance will be emailed to participants after the CTCA REVIEW. To obtain a CME
or CE certificate, healthcare providers must submit a completed evaluation questionnaire.
Upon request, a record of attendance certificate will be provided to other oncology
care professionals for requesting credits in accordance with state nursing boards,
specialty societies, or other professional associations.
Unapproved Uses of Drugs/Devices
In accordance with requirements of the Food and Drug Administration (FDA), the
audience is advised that information presented in this continuing medical education
activity may contain references to unlabeled or unapproved uses of drugs or devices.
Please refer to the FDA-approved package insert for each drug/device for full prescribing
American’s with Disabilities Act (ADA)
Dannemiller and Athena fully comply with the legal requirements of the ADA and
the rules and regulations thereof. If any participant in this educational activity
is in need of accommodations, please contact Nike at firstname.lastname@example.org by July 1, 2014 in order to receive appropriate services at the conference.
For More Information
Athena Education Group, LLC
Attention: Nike Gazonas
River Walk, Building A
201 South Main Street, Suite 15
Lambertville, NJ USA 08530